Skip to content

Parenting Skills for Mothers With Borderline Personality Disorder (BPD)

Preventing Maltreatment and Promoting Mental Health in Children of Mothers With Borderline Personality Disorder - ProChild

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04169048
Acronym
ProChild
Enrollment
240
Registered
2019-11-19
Start date
2020-02-04
Completion date
2023-03-31
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder, Mothers

Brief summary

The first disorder-specific parenting training program for mothers with Borderline Personality Disorder (M-BPD) is evaluated in a randomized controlled trial. The training program is expected to have positive effects on parenting behavior, decrease the risk of maltreatment of the child, and improve emotion regulation in mothers at post treatment and at 6-month follow-up compared to a control group (treatment as usual; TAU). Additionally, disorder-specific aspects of dysfunctional parenting behavior as well as BPD-specific aspects of child maltreatment are compared to a clinical control group (mothers with anxiety and/or depression, M-AD/D) and a healthy control group (M-CON). To assess the differential development of parenting, the risk of maltreatment and emotion dysregulation in untreated M-BPD are compared to M-CON. The investigators expect the difference to increase over time, indicating a worsening in BPD parenting.

Interventions

BEHAVIORALGroup training for mothers with Borderline Personality Disorder

The group programme is designed to teach mothers with BPD parenting skills and to reduce dysfunctional parenting attitudes and strategies. The components are: childrens basics needs, mindfulness, stress and stress reduction, dealing with conflicts, dealing with emotions, dysfunctional attitudes, physical contact, parenting rules, self care.

Sponsors

Ruhr University of Bochum
CollaboratorOTHER
University of Bremen
CollaboratorOTHER
Freie Universität Berlin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

randomized controlled trial with intervention group and waiting group (treatment as usual)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for mothers with BPD: 1. diagnosed with BPD (assessed via SCID-PD) 2. running or completed therapy for BPD symptoms 3. child between 6 months and 6 years 4. living with child or regular (weekly) contact

Exclusion criteria

for the mothers with BPD 1. Acute child endangerment 2. maternal acute suicidality 3. maternal psychotic symptoms (assessed via SCID-CV) 4. maternal acute alcohol or drug dependency (assessed via SCID-CV) 5. maternal diagnosed intellectual disability. Inclusion criteria for mothers with depression and/or anxiety disorders: 1. diagnosed with acute affective or anxiety disorder (assessed via SCID-CV) 2. child between 6 months and 6 years 3. living with child or regular (weekly) contact

Design outcomes

Primary

MeasureTime frameDescription
Change in child neglectday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment) and for the intervention group after each session.Child Neglect Index (CNI; Trocmé, 1996). The CNI measures child neglect, rated by the diagnostician. Range 0-80 with higher values indicating higher neglect.
Change in positive and dysfunctional parenting strategiesday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)Alabama Parenting Questionnaire (Frick, 1991; German DEAPQ-EL-GS; Reichle & Franiek, 2007). The questionnaire assesses several parenting strategies with 7 subscales (positive parenting, responsible parenting, parental Involvement, poor monitoring/supervision, inconsistent discipline, corporal punishment, powerful implementation). Range 6-30, with higher values indicating more of the respective parenting strategy
Change in child rearing competenceday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)Parenting Sense of Competence Scale (PSOC, Gibeau- Wallston & Wandersman, 1978; German FKE; Miller, 2001). The PSOC measures how parents perceive their child rearing competence. Range 0-96 with higher values indicating higher sense of competence.
Change in parental stressday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)Parental Stress Index (PSI, Abidin, 1995; German EBI; Tröster, 2010). The PSI is a dimensional rating of parental stress. Range 48 - 240 with higher values indicating higher stress.
Change in physical and psychological aggression towards childday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)Conflict Tactic Scale - Parent Child (CTS-PC; Strauss, 1998). The CTSPC measures the extent to which a parent has carried out specific acts of physical and psychological aggression. Range 0-300 with higher values indicating higher annual frequency
Change in physical abuse potentialday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)Child Abuse Potential Inventory (CAPI, Milner, 1986, German EBSK; Deegener et al., 2009). The CAPI measures physical abuse potential with reference to the individual burden and three validity scales: a lie scale, a random response scale, and an inconsistency scale. t-values are calculated considering all scales.
Change in dysfunctional discipline practicesday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)Parenting Scale (Arnold, O'Leary, Wolff & Acker, 1993; german version: Erziehungsfragebogen-Kurzform, EFB-K; Miller, 2001). Questionniare measuring dysfunctional discipline practices in parents. Mean values range between 1-7 with higher values indicating more negative parenting strategies.

Secondary

MeasureTime frameDescription
Change in borderline specific thoughts and feelingsday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)Questionnaire of Thoughts and Feelings (QTF, Renneberg et al., 2010). The QTF measures borderline specific thoughts and feelings. Range 1-5 with higher values indicating more BPD-specific thoughts and feelings.
Change in emotion regulationday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). Difficulties in emotion regulation are measured with a) awareness and understanding of emotions; (b) acceptance of emotions; (c) the ability to engage in goal-directed behavior, and refrain from impulsive behavior, when experiencing negative emotions; and (d) access to emotion regulation strategies perceived as effective. Range 36 - 180 with higher values indicating more problems in emotion regulation.
Change in mental distressday 0 (before treatment), week 12 (after treatment), month 9 (6 months after second assessment)Brief Symptom Inventory (BSI, Derogatis, 1975; German: Franke, 2000). The BSI measures mental distress. Results are displayed via t-values.

Other

MeasureTime frameDescription
client satisfactionweek 12 (after treatment) (intervention group only)Client Satisfaction Questionnaire (CSQ-8, Attkisson & Zwick, 1982; German ZUF-8; Schmidt, Lamprecht & Wittmann, 1989). CSQ-8 measures client satisfaction with intervention. Range 8-32 with higher values indicating greater satisfaction.
Negative intervention outcomesweek 12 (after treatment) (intervention group only)Questionniare assessing negative intervention outcomes (INEP, Ladwig, Rief, & Nestoriouc, 2014).The INEP measures negative effects of psychotherapy in different areas of life (intrapersonal change, relationships, friendships, family, malpractice, and stigmatization). Range from -3 to +3. Higher values indicating better therapeutic course.

Countries

Germany

Contacts

Primary ContactCharlotte Rosenbach, Dr.
c.rosenbach@fu-berlin.de00493083851258

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026